about
sameAs
Cancer prevention and control: alarming challenges in ChinaClinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.A population-based study examining hepatitis B virus infection and immunization rates in Northwest ChinaChanges in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated AreaHBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology.Breastfeeding and chronic HBV infection: clinical and social implicationsTLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity.Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University.HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study.Evaluation of mean platelet volume in patients with hepatitis B virus infectionEfficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.Caregiver burden and its determinants among family members of patients with chronic viral hepatitis in Shanghai, China: a community-based survey.Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions.T cell-based therapies for EBV-associated malignancies.Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.Hepatitis C virus infection, Linxian, China.Health care workers in Pearl River Delta Area of China are not vaccinated adequately against hepatitis B: a retrospective cohort studyPractical difficulties in the management of hepatitis B in the Asia-Pacific region.Hepatitis B virus translocates across a trophoblastic barrier.Clonorchis sinensis Co-infection Could Affect the Disease State and Treatment Response of HBV Patients.Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987-2011).Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinomaThe impact of hepatitis B knowledge and stigma on screening in Canadian Chinese personsHepatitis B virus infection and genotype in asymptomatic people from 10 ethnic groups in Yunnan, China.Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine scheduleComparison of drug abuse in Germany and China.Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.Effects of two novel nucleoside analogues on different hepatitis B virus promoters.Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in ChinaSorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma.Impact of the free-vaccine policy on timely initiation and completion of hepatitis B vaccination in Fujian, China.Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study.Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa).Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China.Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy.
P2860
Q28396786-EA3F3E58-738A-48C1-8FFE-A0265C9A69A2Q33330483-31C41C33-27D9-4D26-B71B-BDFBB56065DDQ33618408-A7009AB7-5F8B-4181-8AA9-26530B223B91Q33682797-5A13D59B-2DD8-4554-BE08-2B707A1AF23CQ34169789-5C2922AF-C28C-4329-BD21-8C330B96153BQ34174441-4EE51005-E8E0-46B1-9DA5-1116B7B2B5A9Q34246938-D098025C-73CC-420A-AB43-548EBF66F6CBQ34540395-1EC0B43C-A16C-4652-96F0-F88097FA54A1Q34575243-F11A4626-B72B-45C8-A801-366B0B76CBDDQ34591251-C03FCB74-4542-4173-AB34-91CF5C813942Q34769918-B7B1D09A-46F5-4B8E-8107-932D38BB77F8Q34789906-AD5C9B98-767C-4AB1-917D-F5A200D455E3Q35093074-85C14FB9-7D71-482F-A171-964D85308DE2Q35099170-D716ED52-FFF5-4048-98A9-7CB18EDBBB92Q35609768-225B2B19-BAB2-498D-995F-1387B46F2434Q35632910-1A8EC214-96C7-4034-B12A-EFCB28356913Q35804327-4FC1893A-B04E-4600-891D-0BEB46F89783Q35847888-B726AE5D-202D-4A71-AD46-B2CA900BFF53Q35860206-23B0B965-F69F-49EF-9310-6FF8F3A8C955Q35914415-3E580C65-6BFD-4247-BD03-F45FD8BF7BF7Q36062354-5E750831-0499-4612-AF71-46E772684BBEQ36161857-16B8072A-50AF-4EFD-B0CA-7823CB9265FEQ36224454-D350EED1-9C9D-432D-A7BF-6A509EFDBBE4Q36231824-ACB8BDC4-D17E-4680-9891-6B17ECBDB31DQ36316873-A3BD7C85-DB9B-43B4-A138-91176E935A7BQ36849802-229A5C13-58C3-477C-8F44-6AD152022C35Q36947342-77C0731E-1413-4E24-AE74-A2328D6C93A0Q37065327-58D84CF6-5980-460B-B45E-664104506B9CQ37224376-14EF6EFA-87D9-429A-9120-10885B733648Q37240363-2D8B97B1-B03D-4B7B-BE7A-D73729D82402Q37278075-3FD285CE-6431-4CBE-BA27-E1BBF4822945Q38207487-057CA0E6-5B72-42A0-B028-A1407FB137F7Q40085464-8DCC7FCC-D061-4B60-81DC-D51FDDA15632Q40233377-B19F9691-B2B1-491E-97EB-F560FD471965Q40545036-A3A8F890-5FB6-4759-9788-1D0A8B53930BQ40791821-710721C5-2D87-40DF-98AF-024322E15308Q41721837-BAC2D684-9491-4F66-A6D6-5494D0878DCDQ42035960-FD4E4F43-CCB0-42A1-AA8F-4DF628EFE7CAQ42044622-2C7EAEEC-E895-480F-A60D-F6F2C957FE64Q42121505-4C81F3CB-BEE5-434B-B835-16E0ACF64388
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prevention and control of hepatitis B in China
@ast
Prevention and control of hepatitis B in China
@en
Prevention and control of hepatitis B in China
@nl
type
label
Prevention and control of hepatitis B in China
@ast
Prevention and control of hepatitis B in China
@en
Prevention and control of hepatitis B in China
@nl
prefLabel
Prevention and control of hepatitis B in China
@ast
Prevention and control of hepatitis B in China
@en
Prevention and control of hepatitis B in China
@nl
P2093
P3181
P356
P1476
Prevention and control of hepatitis B in China
@en
P2093
P304
P3181
P356
10.1002/JMV.10094
P407
P577
2002-07-01T00:00:00Z